Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2017-01-18
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


  WINDY CITY TIMES

Forum explores Truvada's use in fighting HIV
by Kate Sosin, Windy City Times
2011-06-22

facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email


When Gladstone Institutes released evidence that Truvada, a one-a-day HIV pill, might prevent HIV in addition to treating it, the news sparked both excitement and skepticism.

The AIDS Healthcare Foundation (AHF), the largest HIV/AIDS medical provider in the country, came out against the use of Truvada for prevention, despite the fact that Gladstone's Iniciativa Profilaxis Preexposicion (iPrEx) trial showed the drugs to be more than 90-percent effective in preventing HIV in those who took it daily.

Experts on the study sat down with Feast of Fun podcasters Fausto FernÃ"s and Marc Felion at Center on Halsted June 15 to talk about what the study means and if Truvada could signal the end of the pandemic. Present were Dr. Robert Grant of Gladstone Institute, Keith Green, director of federal affairs at AIDS Foundation of Chicago, and a youth who participated in a similar study Green conducted in Chicago.

"In our wildest dreams, we did not think [Truvada] would be more than 90-percent effective in those who took it," Grant told the audience.

The findings also astounded Green, who halted Project PrEPare, a similar Chicago study, because he didn't want to continue administering placebos when he knew Truvada worked.

While the effectiveness of Truvada in preventing HIV is clear, the practicality of it remains uncertain. For one, Truvada is meant to be taken daily, which could pose a challenge to many not accustomed to the routine or whose lives don't always allow for consistency, such as youth living on the street. Additionally, Truvada is not without side effects including nausea, although that tends to go away over prolonged use, said Grant.

One barrier in getting people to use Truvada is stigma, Grant said.

"These pills, in particular, have been the one thing that folks want to avoid," he said, adding that fear surrounding HIV/AIDS contributes to fear around taking Truvada for prevention. "It strikes people as a misuse [of the drug]."

The drug could cost as much at $10,000 a year, an impossibly high price for people without insurance. In Illinois, the AIDS Drug Assistance Program (ADAP) which provides antiretrovirals to those who cannot afford them, is already cash-strapped. Truvada used for prevention could compete with Truvada treatments, creating a kind of Catch-22 for service providers who want to end the spread of HIV but also serve those who are positive already.

"We really have an ethical dilemma," Green said.

Still, many insurance companies are interested in Truvada for prevention because even with the cost of the drug, prevention is at least half the cost of treatment.

Rico, the youth who participated in Green's Chicago study on Truvada said that taking the drug made him "more considerate" of his body and protecting himself. He said that he had been hesitant to participate in the study but decided to sign up when he learned of the impact it could have on his community.

Grant and Green did acknowledge that iPrEx study had its shortcomings.

"I started to look at Dr. Grant's work, and those people didn't look like our people," Green said, adding that a low number of youth and African Americans had participated. Grant agreed and noted that their efforts would seek the expertise of Chicago service providers whose work included a diversity of clients. Still he added, the drug seemed to work equally well among people of every race.

As for AHF's critiques of using Truvada for prevention, neither Grant nor Green seemed to give them much weight.

"This is a large corporation, actually that has revenues above 300 million dollars a year, so well above my pay grade," said Grant, who went on to say that he was not certain about why AHF was working to discredit the trial results.

Truvada is awaiting FDA approval before it can be marketed for HIV prevention. Grant said that Gilead, the company that makes Truvada, will likely be hesitant to market the drug for prevention and that it will be up to AIDS service providers to make the leap in making Truvada more accessible.

For some, that leap can't come quickly enough.

"We either pay now or we pay forever," Grant said. "We have a chance now to stop this epidemic."


facebook twitter pin it del.icio.us stumble upon digg google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

Lambda Legal: Price would endanger health of LGBTs, people living with HIV 2017-01-18
Planned Parenthood prepares for fight of its life 2017-01-18
UMC's Bishop Karen Oliveto visits Chicago 2017-01-18
Poll: 10M LGBTQs reside in U.S. 2017-01-18
Riva Lehrer talk on Jan. 25 2017-01-18
Bill T. Jones to speak at DuSable 2017-01-18
Cartooning AIDS' at Gerber/Hart 2017-01-18
Legacy LIVE to present Short Fuse: Story of an AIDS Activist, Sotomayor's story 2017-01-14
Equality California urges Congress to preserve the Affordable Care Act 2017-01-13
Rep. Feigenholtz introduces legislation protecting abortion access 2017-01-13
Gilead Sciences to give $22M in grants to new HIV cure research projects 2017-01-11
Attack on Affordable Care Act: Lambda Legal urges action to save lives 2017-01-11
Local study of injectable HIV drug launches 2017-01-11
Antonio King takes on new CDPH role 2017-01-11
The Fairy Gardener 2017-01-10
ACLU acts to block court order permitting health care discrimination 2017-01-10
Peter Staley to present keynote at MBLGTACC 2017 2017-01-09
Pro-choice march for abortion rights planned for Jan. 15 2017-01-09
Survey shows drug-fueled sex is prevalent with 30% of respondents 2017-01-09
Wild Things Conference to bring together nature enthusiasts, activists, volunteers 2017-01-06
NJ Catholic hospital denies care to trans man, Lambda files suit 2017-01-05
UIC to continue study of risky behavior by sexual-minority women 2017-01-04
ART REVIEW Art AIDS America/Chicago 2017-01-04
Cook County Health & Hospitals part of study to test new HIV-prevention medication 2016-12-28
Heartland official speaks on testing, PrEP outreach 2016-12-28
ART Artivist Monica Raye Simpson talks social justice, childhood 2016-12-27
Chicago Dept. of Public Health appoints LGBTQ liaison 2016-12-21
World news: HIV and the Philippines, Malta's ban, UN news 2016-12-20
Johnson HIV conviction reversed 2016-12-20
Art AIDS exhibit in Chicago through April 2 2016-12-14
All Survivors Project to study, shape policy on male sexual victimization in war 2016-12-14
LGBTQ health conference calls for submissions 2016-12-14
Equality Illinois to honor Lurie 2016-12-14
David France and his guide to 'Survive' 2016-12-14
Agency lends a hand to those with HIV 2016-12-13
One-on-one cuddling sessions redefine touch 2016-12-13
PASSAGES: LGBTQ, HIV/AIDS activist Jimmy Bissonnette dies 2016-12-07
Exhibit curator talks AIDS representation in the art world 2016-12-07
Center joins forces with arts groups at World AIDS Day event 2016-12-07
Art AIDS America recalls changes and a new threat 2016-12-07
 



Copyright © 2017 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor
Sponsor
Sponsor
Sponsor


 



Sponsor

About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage



About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Post an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.